PSS World and Novartis Sign Vaccine Sales Agreement
March 3, 2008
PSS World Medical has entered into a unique agreement with Novartis Vaccines and Diagnostics, to act, under a fee-for-service arrangement, as a sales agent and to provide logistical and related services to its customers for the sale of Novartis’s Fluvirin influenza virus vaccine.
The company’s physician business, Physician Sales & Service (PSS), expects to market and sell a minimum of two million doses of Fluvirin on behalf of Novartis Vaccines to office-based physicians in the upcoming 200-2009 influenza season. The company also said that, orders may be placed for Fluvirin influenza virus vaccine for the 2008-2009 influenza season through Physician Sales & Service offices located nationwide.